Stolper & Co’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.35M | Buy |
55,477
+3,888
| +8% | +$94.3K | 0.44% | 58 |
|
|
2025
Q1 | $1.31M | Buy |
51,589
+1,604
| +3% | +$40.6K | 0.43% | 58 |
|
|
2024
Q4 | $1.33M | Buy |
49,985
+113
| +0.2% | +$3K | 0.44% | 57 |
|
|
2024
Q3 | $1.44M | Sell |
49,872
-318
| -0.6% | -$9.2K | 0.47% | 58 |
|
|
2024
Q2 | $1.4M | Buy |
50,190
+1,841
| +4% | +$51.5K | 0.49% | 57 |
|
|
2024
Q1 | $1.34M | Buy |
48,349
+4,036
| +9% | +$112K | 0.48% | 57 |
|
|
2023
Q4 | $1.28M | Sell |
44,313
-1,807
| -4% | -$52K | 0.51% | 55 |
|
|
2023
Q3 | $1.53M | Buy |
46,120
+1,167
| +3% | +$38.7K | 0.66% | 50 |
|
|
2023
Q2 | $1.65M | Buy |
44,953
+234
| +0.5% | +$8.58K | 0.69% | 47 |
|
|
2023
Q1 | $1.83M | Buy |
44,719
+620
| +1% | +$25.3K | 0.78% | 39 |
|
|
2022
Q4 | $2.26M | Sell |
44,099
-7,237
| -14% | -$371K | 0.99% | 31 |
|
|
2022
Q3 | $2.25M | Buy |
51,336
+2,475
| +5% | +$108K | 1.11% | 32 |
|
|
2022
Q2 | $2.56M | Buy |
48,861
+1,668
| +4% | +$87.5K | 1.2% | 30 |
|
|
2022
Q1 | $2.44M | Buy |
47,193
+1,562
| +3% | +$80.9K | 1.04% | 31 |
|
|
2021
Q4 | $2.7M | Buy |
45,631
+430
| +1% | +$25.4K | 1.2% | 27 |
|
|
2021
Q3 | $1.94M | Buy |
45,201
+959
| +2% | +$41.2K | 0.93% | 33 |
|
|
2021
Q2 | $1.73M | Buy |
44,242
+762
| +2% | +$29.8K | 0.82% | 37 |
|
|
2021
Q1 | $1.58M | Buy |
43,480
+605
| +1% | +$21.9K | 0.81% | 40 |
|
|
2020
Q4 | $1.58M | Sell |
42,875
-1,296
| -3% | -$47.7K | 0.89% | 38 |
|
|
2020
Q3 | $1.54M | Sell |
44,171
-4,020
| -8% | -$140K | 0.99% | 33 |
|
|
2020
Q2 | $1.5M | Sell |
48,191
-3,220
| -6% | -$99.9K | 0.98% | 36 |
|
|
2020
Q1 | $1.59M | Buy |
+51,411
| New | +$1.59M | 1.14% | 34 |
|